We are live on ! Find out more
GRDN

Guardian Pharmacy Services

105 hedge funds and large institutions have $388M invested in Guardian Pharmacy Services in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 46 increasing their positions, 14 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 3

229% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 14

69% more capital invested

Capital invested by funds: $230M → $388M (+$158M)

42% more funds holding

Funds holding: 74105 (+31)

31.83% less ownership

Funds ownership: 111.89%80.06% (-32%)

Holders
105
Holders Change
+31
Holders Change %
+41.89%
% of All Funds
1.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
36
Increased
46
Reduced
14
Closed
3
Calls
Puts
Net Calls
Net Calls Change

GRDN Hedge Fund Activity: Q2 2025 in Review

105 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Guardian Pharmacy Services (GRDN) for Q2 2025, worth a combined $388M — up 69% from $230M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new GRDN positions and 3 closed out — a net gain of 33 holders — while 46 added to existing stakes and 14 trimmed.

The largest buyer was J. Goldman & Co, adding an estimated $21.7M. The largest seller was Nuveen, cutting an estimated $11.3M.

  • 105 institutional investors held Guardian Pharmacy Services (GRDN) as of Q2 2025, up from 74 in Q1 2025.
  • Funds reported $388M of Guardian Pharmacy Services stock for Q2 2025, up 69% quarter-over-quarter.
  • 36 funds opened new Guardian Pharmacy Services positions in Q2 2025 and 3 closed out, a net change of +33 holders.
  • The largest Guardian Pharmacy Services buyer in Q2 2025 was J. Goldman & Co, an estimated $21.7M added.
  • The largest Guardian Pharmacy Services seller in Q2 2025 was Nuveen, an estimated $11.3M sold.

Based on aggregated 13F filings for Q2 2025.